Table 4 Adverse events and adherence to the treatment regimens in the patients*
|  | ANPQ3 group (N = 177) | CQPQ14 group (N = 130) | P value |
|---|---|---|---|
Adverse effects | |||
 Dizziness—no. (%; 95% CI) | 1 (0.6, 0.01–3.1) | 1 (0.8, 0.02–4.2) | 1.000 |
 Nausea—no. (%; 95% CI) | 4 (2.3, 0.6–5.7) | 2 (1.5, 0.2–5.5) | 1.000 |
 Diarrhoea—no. (%; 95% CI) | 1 (0.6, 0.01–3.1) | 0 (0, 0–2.8) | 1.000 |
 Haemolysis—no. (%; 95% CI) | 0 (0, 0–2.1) | 5 (3.9, 1.3–8.8) | 0.0130 |
 Total—no. (%; 95% CI) | 6 (3.4, 1.3–7.3) | 7 (5.4, 2.2–10.8)* | 0.4056 |
Patient adherence | |||
 Person-days of planned medication | 531 | 1820 |  |
 Person-days of actual medication | 523 | 1666 |  |
 Medication percentage (95% CI) | 98.5 (97.1–99.2) | 91.5 (90.2–92.7) |  < 0.0001 |